ECI2: Enoyl-CoA Delta Isomerase 2

Mitochondrial peroxisomal isomerase involved in fatty acid beta-oxidation and bile acid synthesis

Gene Information Card

Symbol ECI2
Full Name Enoyl-CoA Delta Isomerase 2
Gene Type Protein coding
Chromosomal Location 6p24.3
NCBI Gene ID 1632 ncbi.nlm.nih.gov/gene/1632
Ensembl ID ENSG00000112210
UniProt ID O75521
OMIM ID 602172
HGNC ID 2709
Aliases DCI, dodecenoyl-CoA isomerase, peroxisomal 3,2-enoyl-CoA isomerase

Description

ECI2 encodes enoyl-CoA delta isomerase 2, a mitochondrial and peroxisomal enzyme that catalyzes the conversion of 3-cis-enoyl-CoA to 2-trans-enoyl-CoA, a key step in the beta-oxidation of unsaturated fatty acids. The enzyme also participates in bile acid synthesis by isomerizing intermediates. Alternative splicing produces multiple transcript variants.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Peroxisomal biogenesis disorder (Zellweger spectrum) Deficiency in ECI2 disrupts peroxisomal beta-oxidation, leading to accumulation of very long-chain fatty acids and bile acid intermediates. PMID: 10767337
Bile acid synthesis defect (congenital) Impaired isomerase activity reduces conversion of 3-cis-enoyl-CoA intermediates, causing abnormal bile acid profiles. PMID: 15670780
Metabolic syndrome (potential association) Altered fatty acid oxidation efficiency may contribute to lipid dysregulation and insulin resistance. PMID: 21862690

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 High
Kidney 8.3 Medium
Heart 6.1 Medium
Skeletal Muscle 4.7 Low
Brain 2.9 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 14.2 Hepatocellular carcinoma cell line; high expression
HEK293 7.8 Embryonic kidney cells; moderate expression
HeLa 5.3 Cervical carcinoma cells; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense <0.01% Loss of start codon; likely loss of function
c.287C>T (p.Pro96Leu) Missense 0.02% Reduced enzyme activity in vitro
c.502G>A (p.Gly168Arg) Missense <0.01% Impaired substrate binding
Mutation functional classification

Loss of Function (LOF)

Mutations that abolish or severely reduce isomerase activity, such as start codon loss or catalytic site disruptions, lead to impaired fatty acid oxidation and bile acid synthesis.

Gain of Function (GOF)

No gain-of-function mutations have been reported for ECI2.

Dominant Negative (DN)

No dominant-negative mutations have been characterized for ECI2.

Gene Ontology (GO)

• dodecenoyl-CoA delta-isomerase activity (GO:0004165) peroxisome (GO:0005777)
mitochondrion (GO:0005739) fatty acid beta-oxidation (GO:0006635)
bile acid metabolic process (GO:0008206) • coenzyme A binding (GO:0050662)

Pathways

Fatty acid beta-oxidation (unsaturated
odd-numbered)
Bile acid biosynthesis (classic pathway)
Peroxisomal lipid metabolism

Protein Summary

ECI2 encodes a 42 kDa protein that localizes to both mitochondria and peroxisomes. The enzyme acts as a delta(3),delta(2)-enoyl-CoA isomerase, converting 3-cis-enoyl-CoA to 2-trans-enoyl-CoA, essential for the beta-oxidation of unsaturated fatty acids with double bonds at odd-numbered positions. It also isomerizes 3-cis-enoyl-CoA intermediates in bile acid synthesis. The protein forms homodimers and contains a conserved enoyl-CoA isomerase domain.

Related Products

Product name Cat.No. Species Gene ID
ECI2 Knockout HEK293 Cell Line EDJ-KQ3819 Human 10455 Details Get a Quote
ECI2 Knockout A-549 Cell Line EDJ-KQ25952 Human 10455 Details Get a Quote
ECI2 Knockout HCT 116 Cell Line EDJ-KQ25953 Human 10455 Details Get a Quote
ECI2 Knockout HeLa Cell Line EDJ-KQ25954 Human 10455 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: